Codes / ICD10CM / H35.3111

H35.3111 Nonexudative age-related macular degeneration, right eye, early dry stage

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Nonexudative Age-Related Macular Degeneration, Right Eye, Early Dry Stage

Summary

Nonexudative age-related macular degeneration (AMD) is a chronic eye condition affecting the macula, the central part of the retina responsible for sharp central vision. It is characterized by gradual macular deterioration without fluid leakage or bleeding, leading to blurred or reduced vision. This form is commonly referred to as "dry AMD." The early dry stage involves mild changes, such as small drusen or mild pigmentary alterations, without significant vision loss.

Causes

The exact cause of nonexudative AMD is not fully understood, but it involves the degeneration of retinal cells and the accumulation of drusen (yellow deposits) under the retina. Oxidative stress and inflammation in retinal tissues are also believed to contribute to the condition.

Risk Factors

  • Increasing age, especially over 50.
  • Family history of macular degeneration.
  • Smoking and tobacco use.
  • Obesity and high cholesterol.
  • Lack of exercise and poor diet lacking antioxidants and zinc.

Symptoms

  • Blurred or reduced central vision in the right eye.
  • Difficulty recognizing faces or reading.
  • Need for brighter lighting when working or reading.
  • Haziness in overall vision.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilation, to assess the macula. Optical coherence tomography (OCT) is used to visualize retinal layers, and an Amsler grid test detects vision distortions. Fundus photography may also be performed to inspect the macula for drusen or pigmentary changes.

Treatment Options

  • Antioxidant and zinc supplements (AREDS formula) to slow progression.
  • Lifestyle modifications such as smoking cessation and diet improvement.
  • Regular monitoring with eye exams to track changes.

Prognosis and Follow-Up

Nonexudative AMD progresses slowly, and vision loss is typically gradual. Early-stage disease may not cause significant symptoms, but regular follow-up is essential to monitor for progression to intermediate or advanced stages. Most patients maintain functional vision, but some may experience mild to moderate vision impairment over time.

Complications

While nonexudative AMD does not involve fluid leakage or bleeding, it can progress to advanced stages, including geographic atrophy, which may lead to more severe vision loss. There is also a risk of developing neovascular (wet) AMD, which can cause rapid vision deterioration.

Lifestyle & Prevention

  • Maintain a diet rich in antioxidants and omega-3 fatty acids.
  • Avoid smoking and limit alcohol consumption.
  • Exercise regularly to support overall health.
  • Protect eyes from excessive UV exposure with sunglasses.
  • Manage blood pressure and cholesterol levels.

When to Seek Professional Help

Seek prompt medical attention if you experience sudden changes in vision, such as blurriness, distortion, or blind spots, or if symptoms worsen despite monitoring. Early intervention is critical for managing progression and addressing complications.

Tips for Medical Coders

Document the specific eye (right eye) and stage (early dry) to ensure accurate coding. Include clinical details such as drusen size, pigmentary changes, or visual acuity measurements to support the diagnosis. Verify that the documentation aligns with the criteria for early nonexudative AMD to avoid miscoding.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

H35.3111 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.